Dechra Pharmaceuticals PLC
OTC: DPHAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Ian D. Page
- Employees
- 2,457
- Headquarters
- Northwich, United Kingdom
- IPO year
- 2018
- Market cap
- $5.6B
- Website
- https://www.dechra.com
Loading DPHAY…
Loading profile data…Frequently asked questions about DPHAY
What does Dechra Pharmaceuticals PLC (DPHAY) do?
Dechra Pharmaceuticals PLC (DPHAY) is dedicated to the development, manufacturing, regulatory approval, marketing, and sale of veterinary medications and related goods specifically for animal health professionals. The company's operations are structured into three key divisions: European Pharmaceuticals, North American Pharmaceuticals, and Pharm...
Where does DPHAY trade?
Dechra Pharmaceuticals PLC (DPHAY) trades on the Other OTC.
What sector is DPHAY in?
Dechra Pharmaceuticals PLC (DPHAY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Dechra Pharmaceuticals PLC?
Ian D. Page is the chief executive officer of Dechra Pharmaceuticals PLC (DPHAY).
Where is Dechra Pharmaceuticals PLC headquartered?
Dechra Pharmaceuticals PLC is headquartered in United Kingdom.
Does DPHAY pay a dividend?
Yes — Dechra Pharmaceuticals PLC (DPHAY) paid a trailing twelve-month dividend of USD 0.31 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did DPHAY go public?
Dechra Pharmaceuticals PLC (DPHAY) completed its initial public offering in 2018.
Is DPHAY an ADR?
Yes — DPHAY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Dechra Pharmaceuticals PLC reporting and dividends follow the underlying issuer.